Glydip M 2mg/500mg Tablet

Short Description

Glydip M 2mg/500mg Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults.

Dosage Form

Tablet

Introduction

Glydip M 2mg/500mg Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glydip M 2mg/500mg Tablet is to be taken with food.

Glydip M 2mg/500mg Tablet is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.

You have been prescribed this combination medicine as it can control blood sugar better than metformin alone. You should continue to exercise regularly eat a healthy diet and take your other diabetes medicines along with Glydip M 2mg/500mg Tablet. Take it with food to lower your chance of having an upset stomach. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting and stomach pain as Glydip M 2mg/500mg Tablet may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite or yellowing of the eyes or skin (jaundice).